000 01628nam  2200337zi 4500
0019.925059
003CaOODSP
00520240724140233
006m     o  d f      
007cr |n|||||||||
008230714e20230911onc     o    f000 0 eng d
020 |a9780660494999
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH164-243/2023E-1-PDF
24500|aPerformance standards for the fees in respect of drugs and medical devices order.
250 |a[September 11, 2023 edition].
264 1|a[Ottawa] : |bHealth Canada = Santé Canada, |cSeptember 11, 2023.
264 4|c©2023
300 |a1 online resource (10 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Normes de rendement pour l'arrêté sur les prix à payer à l'égard des drogues et instruments médicaux.
500 |a"Pub.: 230242."
650 0|aMedical instruments and apparatus industry|xLicenses|xFees|zCanada.
7101 |aCanada. |bHealth Canada, |eissuing body.
77508|tNormes de rendement pour l'arrêté sur les prix à payer à l'égard des drogues et instruments médicaux.|w(CaOODSP)9.925060
794 |tPerformance standards for the fees in respect of drugs and medical devices order.|b[February 16, 2024 edition]|w(CaOODSP)9.932867
795 |tPerformance standards for the fees in respect of drugs and medical devices order.|b[November 1, 2022 edition]|w9.920033
85640|qPDF|s488 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H164-243-2023-eng-1.pdf